With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|ECM-targeted CAR T-cell therapy for high-grade glioma||St. Jude Children's Research Hospital / Jessica Wagner, PhD||Young Investigator Grants||2019||Tennessee|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|The Role of Germline Variants in Infant Leukemogenesis||Washington University / Margaret Ferris, MD/PhD||Young Investigator Grants||2019||Missouri|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|
|Novel Genomic Drivers in Pediatric Polyposis Syndromes||Children's Hospital of Philadelphia / Suzanne MacFarland, MD||Young Investigator Grants||2019||Pennsylvania|
|Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance||Washington University / Nicole Brossier, MD/PhD||Young Investigator Grants||2019||Missouri|
|Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing||St. Jude Children's Research Hospital / Anand Patel, MD/PhD||Young Investigator Grants||2019||Tennessee|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Regina Myers, MD||Young Investigator Grants||2019||Pennsylvania|